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Background: Permanent pacemaker implantation is a minimally invasive surgical procedure in the management of 
patients with cardiac problems. However, complications during and after implantation are not uncommon.  There is lack 
of evidences in rate of complications with the selection of pacemakers in Nepal. Therefore, this study was performed 
to compare the frequency of implantation and complication rate between single chamber and dual chamber pacemaker. 
Methods:  The present study is based on all consecutive pacemaker implantations in a single centre between April 2014 
and May 2015. A total of 116 patients were categorized into two cohorts according to the type of pacemaker implanted- 
single chamber or dual chamber. All patients had regular 2-weeks follow-up intervals with standardized documentation 
of all relevant patient data till 6-week after implantation. Data were presented as means ± standard deviation (SD) for 
continuous variables and as proportions for categorical variables. Comparison of continuous variables between the 
groups was made with independent Student’s t-test. For discrete variables distribution between groups were compared 
with Chi-square test. 
Results: The mean age (±SD) of total population at implant was 64.08 (± 15.09) years. Dual chamber units were 
implanted in 44 (37.93%) of patients, single chamber in 72 (62.06%). Only 14 women (31.81%) received dual 
chamber compared with 42 women (58.33%) who received single chamber (Chi-square=18, DF=1, P = 0.0084). 
Complete atrioventricular block was the commonest (56.03%) indication for permanent pacemaker insertion followed 
by sick sinus syndrome (33.62%), symptomatic high-grade AV block (11.20%). Hypertension (dual chamber 21.55%, 
single chamber 40.51%) was the most common comorbidity in both cohorts. Complications occurred in 11 (9.48%) 
patients. More proportion of complication occurred in single chamber group (9 patients, 12.50%) than in dual chamber 
(2 patients, 4.54%). Complications occurring in dual chamber group include pocket hematoma 1 patient (2.27%) 
and arrhythmia in 1 patient (2.27%). Similarly, complications occurring in single chamber include RV perforation in 
two patients (2.77%) and one each (1.38%) had pocket hematoma, pneumothorax, infection, swelling at pocket site, 
arrhythmia in the form of NSVT, leads displacement, DVT and mortality.
Conclusions: Women were more likely to receive single chamber systems than men. More proportion of complication 
occurred in single chamber group than in dual chamber. Future prospective studies on larger number of patients are 
needed to confirm and support our findings. 
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INTRODUCTION
Permanent pacemaker implantation is one of the most 
common therapeutic or prophylactic strategies in the 
management of patients with cardiac problems at 
present.1 The basic function of the pacemaker is to pace 
the heart in the absence of intrinsic impulses, and to 
recognize intrinsic cardiac electrical activity if present 
and restrain pacing consequently. 
Optimal selection of the single or dual chamber 
pacemaker devices depend in terms of arrhythmia, their 
cost effectiveness and longevity.2 However, considerable 
differences have been reported in the frequency of 
implantation of pacemakers and in the system selected.3,4 
Some authors argued against dual chamber pacing on the 
basis of cost, a more complex implantation procedure, 
and an apparently higher complication rate than single 
chamber systems.5
Despite the relative ease of device implantation, 
the complication risk is still present and sometimes 
underestimated.6 Therefore, this study was performed 
to compare complication rate between single chamber 
and dual chamber pacemakers. 
METHODS
This was hospital based, prospective study conducted 
at Manmohan Cardiothoracic Vascular and Transplant 
Centre (MCVTC), Department of cardiology, Maharajgunj, 
Kathmandu between April 2014 and May 2015. A total of 
116 patients were categorized into two cohorts according 
to the type of pacemaker implanted- single chamber or 
dual chamber. The study site, one of the tertiary level 
cardiac centres in Nepal, provides advanced cardiac 
care to the patients from all over the country.
Study participants were the patients attending Out 
Patients Department (OPD) and emergency of MCVTC 
and subsequently admitting for permanent pacemaker 
implantation. Patients who had pre-existing permanent 
cardiac pacemaker (PM), defibrillator (ICD) or cardiac 
resynchronization therapy device (CRT) were excluded 
from the study. All eligible participants during 14 months 
period were enrolled in the study and followed up to 
6-weeks after implantation. No one was lost to follow 
up.
Participants provided written informed consent 
after detailed explanation of research purpose and 
assurance of maintaining privacy and confidentiality. 
The institutional review board of institute of medicine 
assessed the ethical part and approved the study.  
At initial visit, patients’ detail history was recorded. The 
common co-morbidities included were left ventricular 
dysfunction (LVD), hypertension, diabetes mellitus (DM), 
chronic kidney diseases (CKD), coronary artery diseases 
(CAD), chronic obstructive pulmonary disease (COPD) 
and deep vein thrombosis (DVT). Likewise, information 
related to prominent symptoms such as syncope and 
palpitation, and major indications like complete heart 
block (CHB), sick sinus syndrome (SSS) and symptomatic 
high degree Atrioventricular (AV) block were also noted. 
Permanent pacemaker implantations were performed in 
a fluoroscopic C arm equipped theatre. The implanta-
tion team consisted of a consultant who performed the 
implantation, Doctor of Medicine (DM) resident posted 
in cardiac catheterization laboratory, a cardiac physiolo-
gist who checked the pacemaker parameters, a pace-
maker technician to operate the fluoroscope for imaging 
and a scrub nurse. 
After implantation, patients were closely monitored on 
the ward for 48 hours followed by every two week inten-
sive assessments for next 6 weeks to find if any compli-
cations occurred. 
Data were compiled, edited and checked to maintain 
consistency prior to coding and entering in Epidata 
V.2.1 and exporting to SPSS V.16.0 for further analysis. 
For inferential statistics, chi-square and t tests were 
conducted to compare the proportions of categorical 
and mean of continuous variables respectively. A p-value 
of less than 0.05 was considered statistically significant.
RESULTS
The baseline characteristics are presented in table 1. 
The mean (SD) age of total population at implant was 
64.08 ± 15.09 years. Mean age of patients who received 
dual chamber pacemaker was 64.92 ± 13.20 years, 
not significantly different from those received single 
chamber pacemaker (65.80 ± 12.81 years, P = 0.80). 
During the study period, a total of 54 women (48.27%) 
received pacemakers. Overall the mean age of women at 
pacemaker implantation was not significantly different 
from the age of men (63.2 ± 11.3 years vs. 65.0 ± 12.4 
years, P= 0.37). 
Dual chamber units were implanted in 44 (37.93%) of 
patients, single chamber in 72 (62.06%). Only 14 women 
(12.06%) received dual chamber compared with 42 
women (36.20%) who received single chamber (Chi-
square=18, DF=1, P = 0.0084).
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Table 1. Baseline characteristics of patients 













Female 56   (48.27%) 14 (31.81) 42 (58.33) 0.0084
Male 60 (51.72%)     30 (68.18) 30 (41.66) 0.56
Comorbidities
LV Dysfunction         24 (20.69%) 9 (20.45) 15 (20.88) 0.20
Diabetes mellitus  13 (11.20%) 5 (11.36) 9 (12.50) 0.58
Hypertension                    72 (62.06%) 25 (56.81) 47(65.27) 0.11
CAD                                     9 (7.75%) 4 (9.09) 5 (6.94) 0.87
CKD                                     28 (24.13%) 11 (25.00) 17 (23.61) 0.36
COPD                                    5 (4.31%) 2 (4.54) 3 (4.16) 0.09
DVT                                     2 (1.72%) 0 (0) 2 (2.77) 0.59
Indications
CHB                                     65 (56.03%) 21 (47.72) 44 (37.93)  0.91
SSS                                      39 (33.62%) 19 (43.18) 20 (17.24)  0.44
Symptomatic high 
degree AV block       
13 (11.20%) 6 (13.63) 7 (6.03)   0.51
Complete atrioventricular block was the commonest (65 
patients; 56.03%) indication for permanent pacemaker 
insertion followed by sick sinus syndrome (39 patients; 
33.62%), symptomatic high-grade AV block (13 patients; 
11.20%). 
Hypertension (62.06% of total population) was the most 
common comorbid condition underlying indications for 
pacemaker implantation.
CKD was the second most common disease prevalent 
among both cohorts. CKD was present in 24.13% of total 
implantation.
Following hypertension and CKD, LV dysfunction was 
present in 20.69% of total population. 
Diabetes mellitus was present in 11.20%. Similarly, CAD 
was present in 7.75%.
COPD was present in 5 patients (4.31%). DVT was present 
in two patients (1.72%).
Complications occurred in 11 (9.48%) patients. More 
proportion of complication occurred in single chamber 
group (9 patients, 12.50%) than in dual chamber (2 pa-
tients, 4.54%). Complications occurring in dual chamber 
group include pocket hematoma 1 patient (2.27%) and 
arrhythmia in 1 patient (2.27%). Similarly, complications 
occurring in single chamber include pocket hematoma 
(1 patient, %), RV perforation in two patients (2.77%), 
pneumothorax in 1 patient (1.38%), infection in 1 pa-
tient (1.38%), swelling at pocket site in 1 patient(1.38%), 
arrhythmias in form of NSVT in 1 patient (1.38%),  leads 
displacement in 1 patient in single chamber (1.38%) , 
DVT in 1 patient(1.38%), and death in 1 patient(1.38%), 
DVT in 1 patient (1.38%)and death (1.38%).
DISCUSSION 
We performed the prospective study of indications, 
comorbidities and complications related to permanent 
pacemaker implantation. Our goal was to collect 
complications within the 6-weeks period from the time 
of implantation.
The present study had some limitations. First, study 
population was not evenly distributed to each type of 
pacemaker cohort. The sample size of the total study 
population was too small to allow for a generalization of 
the results. Second, the study was non-randomized, with 
regard to implanted pacemaker type. Third, we did not 
take other complications, such as pacemaker syndrome, 
quality of life, and events related to venous access into 
consideration. Large prospective randomized studies 
that include clinical endpoints such as survival or quality 
of life are needed to investigate this difference in more 
detail and reveal its potential implications. 
Analysis of data from 116 patients suggests a sex bias in 
choice of a pacemaker system. Women were more likely 
to receive single chamber systems and less likely to 
receive dual chamber than men. These findings cannot 
be explained by differences in the underlying cardiac 
disorders or demographic data. Doctors generally 
implant single chamber pacemakers in elderly patients 
rather than dual chamber systems. Several studies of 
factors influencing cardiovascular interventions showed 
that sex was no longer a determinant once clinical 
variables had been adjusted for.7 Our results agree with 
two retrospective studies in the United States in which 
women were found to receive a dual chamber system 
less frequently than men.8 
Dual chamber pacemakers have been shown to offer 
haemodynamic advantages over single chamber 
pacemaker.9 Although there is evidence that patients 
treated by advanced pacing have a better quality of life, 
it is not known whether this improvement is equal in 
men and women.
What other reasons could there be for doctors deciding 
in favour of a single chamber pacemaker in women? 
Firstly, there are some “soft” indications for implanting 
pacemakers (class II indications in the American College 
of Cardiology/American Heart Association guidelines). 
Doctors are known to behave differently towards men 
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and women as far as both diagnostic and therapeutic 
strategies are concerned.10 
Doctors seeing women with “soft” indications may tend 
to implant single chamber pacemakers whereas they 
choose dual chamber for men. Some of the “hard” 
indications may also be being neglected in women. 
Women often present their symptoms differently from 
men.11 
They are more likely to receive the same treatment as 
men if they present their symptoms as men do.12 
Finally, we found some published evidence that women 
sometimes reject sophisticated care in favour of more 
simple treatments. They may therefore choose not to 
have dual chamber systems.13    
Since the implantation of the first artificial pacemaker 
in 1958 these devices have become the treatment of 
choice in bradycardias.14  
There are two often related reasons for implanting 
a cardiac pacemaker: to relieve symptoms and to 
improve survival. Most patients treated with pacemaker 
implantation are elderly persons with either chronic 
atrioventricular-block (AVB) or sick sinus syndrome 
(SSS).15 
Permanent pacing for complete heart block was the 
commonest indication in this study (56.03%) and it 
was comparable (42%) to that reported from a similar 
population. Untreated complete heart block has a 
one year and five year mortality of 50% and 75%–90% 
respectively; while survival is 70%–85% at five years in 
those paced. 16
Sick sinus syndrome was responsible for 33.62% of 
patients paced in this report and it was identical to that 
reported from a similar district general population in UK.
Pacing for sick sinus syndrome is based on the association 
of symptoms with specific dysrrhythmia5; it effectively 
relieves symptoms of bradycardia and can facilitate 
more aggressive drug treatment of tachyarrhythmias,17 
but there is no evidence that pacing asymptomatic 
patients improves prognosis.18 
Our study was undertaken to assess the complication 
rate in a tertiary cardiac centre in Kathmandu. Most 
procedures are performed by cardiologists. Studies 
comparing the complication rates of dual versus single 
chamber pacemaker implantation have previously 
reported either no difference19 or a higher complication 
rate for dual than single chamber pacing.20
Implantation of permanent pacemakers (PM) represents 
an effective treatment option for several cardiac 
arrhythmias. The incidence of acute complications from 
device implantation, such as pneumothorax, cardiac 
effusion, and lead perforation ranges from 1% to 7%.21 
The determination of procedural adverse events is 
complex, related to the specific type of procedure and 
patient comorbidities such hypertension.22 
Complications associated with the implantation 
procedure itself have occurred in nine patients. Two 
patients had RV perforation and treated urgently surgical 
intervention. In other one patient the catheter electrode 
dislodged and the procedure had to be repeated. The 
bipolar catheter electrode perforated the myocardium 
in RV apex, in the same area where the temporary 
catheter had perforated a few days earlier. The other 
cardiac perforations occurred during the procedure and 
treated by pigtail insertion.  
In our study, pocket hematoma and RV perforation were 
two most frequent early complications of pacemaker. 
The incidence of perforation after permanent pacemaker 
is reportedly between 0.3% and 1.2%.23 
The complications rate (1.723%) was comparable to that 
reported (2.48%) from a district general hospital and 
similar to that reported (2.8%) from a tertiary centre.24 
Infection in a permanently implanted PM is a serious 
complication. It may occur either as a surgical site 
infection (SSI), occurring within 1 year after implantation, 
or as late-onset endocarditis. Rates of infection after 
system placement have varied considerably, from 0.13% 
to 19.9%, and antimicrobial therapy alone (without 
removal of the entire system) is complicated by mortality 
and frequent infection relapse. Pacemaker implantation 
rates are on the rise worldwide, and the population of 
patients living with a PM is growing.25 
Implantation of dual- and triple-chamber devices was 
associated with a two-fold higher risk of infection than 
implantation of single-chamber devices.26 We observed 
no difference in the incidence of infections between the 
two patient groups.
The overall mortality rate in all patients was 0.86%, 
due to causes unrelated to the pacemaker implantation 
itself.
Our finding of lower rate of complication associated with 
infection might be due to preprocedural use of broad 
spectrum antibiotic.
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In addition, a large (500 patients) prospective randomized 
study showed that, with meticulous preoperative skin 
preparation, use of a topical antibiotic spray into the 
pacemaker pocket, and close postoperative follow up, 
patients gained no advantage from routine prescription 
of prophylactic antibiotics.27
CONCLUSIONS
Women were more likely to receive single chamber 
systems and less likely to receive dual chamber systems 
than men. More proportion of complication occurred 
in single chamber group than in dual chamber. None of 
the complications were found to be related significantly 
with types of pacemaker implanted. Future prospective 
studies on larger number of patients are needed to 
confirm and support our findings.
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